Home Cancer

Keyword: Cancer

79 results found

As the coronavirus pandemic continues, fewer Canadian benefits plan members are making drug claims, according to Telus Health’s annual drug trends report. The report, based on the drug claims activity of more than 10 million plan members in 2021, found just 56 per cent made a claim in 2021, reflecting a decreased frequency of in-person […]

  • By: Staff
  • June 23, 2022 June 22, 2022
  • 09:00

While medications used for treating inflammatory disease accounted for just 0.7 per cent of claims across Telus Health’s Canadian block of business in 2021, they represent the largest percentage of eligible drug costs at 12.6 per cent, due to the prevalence of high-cost treatments in this drug class. By comparison, diabetes medications accounted for 12 […]

In Canada, the year-over-year cost increase for claims under a medical plan on a per-person basis is projected to reach 8.6 per cent this year, up from eight per cent in 2021, according to a new report by Mercer Canada. The report, which analyzed responses from 210 insurers across 59 countries, found the year-over-year cost […]

  • By: Staff
  • March 30, 2022 March 29, 2022
  • 09:00

Employer-sponsored health benefits cost trends are expected to increase 8.1 per cent on average globally in 2022, according to a new survey by Willis Towers Watson. The survey, which polled medical insurers across various geographic regions, found cost trends are expected to be as high as 14.2 per cent in Latin America, followed by 10.6 […]

  • By: Staff
  • November 19, 2021 November 19, 2021
  • 15:00
Editorial: Looking back — and ahead — in an unprecedented year

With the Delta variant leading the coronavirus pandemic in a renewed surge, employers continue to have a surplus of challenges, regardless of whether or not they’re planning a return to the workplace. I discussed this latter challenge in my Editorial last month, but at the risk of heaping on more doom and gloom, it may […]

As innovative medicines become more widely covered in workplace drug plans, employers are tasked with finding new ways to control costs while ensuring members receive the best value. “Obviously, this is good because such offers provide more treatments for employees and their families that can help get them back to the workplace sooner rather than […]

While the rates of drug and disability claims are returning to their pre-pandemic levels, employers are still contending with the impact of the coronavirus crisis on their benefits plans. Following the declaration of the pandemic in March 2020, there was a subsequent surge in drug claims attributed to medication stockpiling, said Frédéric Leblanc, strategic advisor […]

Copyright_Wavebreak Media Ltd_123RF

When a 46-year-old woman was diagnosed in early 2016 with stage-two triple-negative breast cancer, she started planning her return to full-time work at almost the same time she began treatment. “It’s interesting because when we think of return-to-work planning, we think of starting to talk about this toward the end of the treatment phase,” said […]

Webinar: Current health-care policies impacting private drug coverage

On May 12, Benefits Canada hosted a webinar to discuss the pharmaceutical industry’s efforts during the coronavirus crisis, as well as some key policy issues for Canadian insurers and their potential impact from the private-payer perspective. Since the end of April, 139 coronavirus treatments have been under investigation and Health Canada has approved several clinical trials […]

Specialty drug usage, traditional drug costs drive small rise in 2019 spending: report

Private drug plans saw a slight uptick in costs in 2019 due to the increased use of specialty drugs and higher price points for traditional medications, according to Express Scripts Canada’s annual drug trends report. The report found private drug plan spending per claimant increased one per cent over 2018’s figures. Plans’ annual spend per claimant on […]

  • By: Staff
  • April 14, 2020 November 12, 2020
  • 10:00